Literature DB >> 24463844

Serum cholinesterase is an important prognostic factor in chronic heart failure.

Takamasa Sato1, Hiroyuki Yamauchi, Satoshi Suzuki, Akiomi Yoshihisa, Takayoshi Yamaki, Koichi Sugimoto, Hiroyuki Kunii, Kazuhiko Nakazato, Hitoshi Suzuki, Shu-ichi Saitoh, Yasuchika Takeishi.   

Abstract

We determine the importance of indicators of nutrition including lymphocyte, total protein, albumin, cholinesterase and body mass index, and compare the prognostic significance in chronic heart failure (CHF). We examined consecutive 465 CHF patients (376 males, age 62 ± 14 years) who underwent cardiopulmonary exercise testing, echocardiography and blood examination including indicators of nutrition at the same time in our hospital. The patients were followed up [median period 766 days (interquartile range 500-1060)] to register cardiac deaths and rehospitalization due to worsening heart failure. There were 180 cardiac events during the follow-up periods. Patients with cardiac events had lower cholinesterase level than those without events (P < 0.001). On the receiver operating characteristic analysis, the best cut-off value for cholinesterase was 240 U/l (area under the curve 0.720). In the Kaplan-Meier analysis, patients with cholinesterase <240 U/l had significantly higher cardiac event rates than those with cholinesterase >240 U/l. Multivariable Cox proportional hazards model demonstrated that NYHA class III [hazard ratio (HR): 1.688, 95 % confidence interval (CI) 1.062-2.684, P = 0.027], eGFR (HR: 0.983, 95 % CI 0.971-0.995, P = 0.006), sodium concentration (HR: 0.947, 95 % CI 0.897-0.999, P < 0.046), log BNP (HR: 1.880, 95 % CI 1.509-2.341, P < 0.001), cholinesterase (HR: 0.996, 95 % CI 0.993-0.998, P = 0.002) and exertional periodic breathing (HR: 1.619, 95 % CI 1.098-2.388, P = 0.015) were independent factors to predict adverse clinical outcomes. Serum cholinesterase level was an important prognostic factor in CHF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463844     DOI: 10.1007/s00380-014-0469-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology.

Authors:  Marie Gerhard-Herman; Julius M Gardin; Michael Jaff; Emile Mohler; Mary Roman; Tasneem Z Naqvi
Journal:  J Am Soc Echocardiogr       Date:  2006-08       Impact factor: 5.251

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

4.  Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava.

Authors:  B J Kircher; R B Himelman; N B Schiller
Journal:  Am J Cardiol       Date:  1990-08-15       Impact factor: 2.778

5.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

6.  Analysis of 10-year nationwide population-based data on sex differences in hospitalization for heart failure.

Authors:  Hung-Yu Yang; Wan-Chun Chiu; Jen-Hung Huang; Chien-Yeh Hsu; Yung-Kuo Lin; Yi-Jen Chen
Journal:  Heart Vessels       Date:  2012-10-23       Impact factor: 2.037

7.  Wasting as independent risk factor for mortality in chronic heart failure.

Authors:  S D Anker; P Ponikowski; S Varney; T P Chua; A L Clark; K M Webb-Peploe; D Harrington; W J Kox; P A Poole-Wilson; A J Coats
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

8.  Albumin levels predict survival in patients with heart failure and preserved ejection fraction.

Authors:  Ming Liu; Chin-Pang Chan; Bryan P Yan; Qing Zhang; Yat-Yin Lam; Rui-Jie Li; John E Sanderson; Andrew J S Coats; Jing-Ping Sun; Gabriel Wai-Kwok Yip; Cheuk-Man Yu
Journal:  Eur J Heart Fail       Date:  2011-12-07       Impact factor: 15.534

9.  Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation.

Authors:  Joao J Leite; Alfredo J Mansur; Humberto F G de Freitas; Paulo R Chizola; Edimar A Bocchi; Mario Terra-Filho; J Alberto Neder; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

View more
  12 in total

1.  Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.

Authors:  Hitoshi Suzuki; Minoru Nodera; Masashi Kamioka; Takashi Kaneshiro; Yoshiyuki Kamiyama; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2017-02-08       Impact factor: 2.037

2.  Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.

Authors:  Atsushi Okada; Hideaki Kanzaki; Yasuhiro Hamatani; Seiji Takashio; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Satoshi Yasuda; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2017-11-02       Impact factor: 2.037

3.  Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.

Authors:  Enrico Ammirati; Fabrizio G Oliva; Tiziano Colombo; Claudio F Russo; Manlio G Cipriani; Andrea Garascia; Valentina Guida; Giulia Colombo; Alessandro Verde; Enrico Perna; Aldo Cannata; Roberto Paino; Luigi Martinelli; Maria Frigerio
Journal:  Heart Vessels       Date:  2015-03-04       Impact factor: 2.037

4.  Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.

Authors:  Shinpei Kadowaki; Tetsuro Shishido; Yuki Honda; Taro Narumi; Yoichiro Otaki; Daisuke Kinoshita; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Isao Kubota
Journal:  Heart Vessels       Date:  2015-01-24       Impact factor: 2.037

5.  Low serum cholinesterase predicts complication risk after orthopedic surgery in elderly patients: an observational pilot study.

Authors:  Mitsuhiro Matsuo; Tohru Yamagami
Journal:  JA Clin Rep       Date:  2019-06-14

6.  Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry.

Authors:  Masahiro Seo; Takahisa Yamada; Shunsuke Tamaki; Shungo Hikoso; Yoshio Yasumura; Yoshiharu Higuchi; Yusuke Nakagawa; Masaaki Uematsu; Haruhiko Abe; Hisakazu Fuji; Toshiaki Mano; Daisaku Nakatani; Masatake Fukunami; Yasushi Sakata
Journal:  J Am Heart Assoc       Date:  2019-12-18       Impact factor: 5.501

7.  Admission serum cholinesterase concentration for prediction of in-hospital mortality in very elderly patients with acute ischemic stroke: a retrospective study.

Authors:  Mingquan Li; Yan Chen; Yanli Zhang; Xiaoyun Liu; Tiantian Xie; Jingjing Yin; Liumin Wang; Shucheng Gang; Jinjin Chen; Ling Liu; Fang Yang; Tongchao Geng
Journal:  Aging Clin Exp Res       Date:  2020-02-18       Impact factor: 3.636

8.  Influence of Serum Cholinesterase Levels on Patients Suspected of Having Stable Coronary Artery Disease.

Authors:  Takahiro Mito; Masao Takemoto; Yoshibumi Antoku; Atsushi Tanaka; Atsutoshi Matsuo; Satoru Hida; Kiyonobu Yoshitake; Ken-Ichi Kosuga; Shin-Ichiro Miura
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

9.  Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.

Authors:  Bang-Ning Cheng; Yu-Lian Jin; Bi-Quan Chen; Li-Yan Zhu; Zi-Cheng Xu; Tao Shen
Journal:  Infect Dis Poverty       Date:  2016-03-29       Impact factor: 4.520

10.  Liver Congestion Assessed by Hepatic Vein Waveforms in Patients With Heart Failure.

Authors:  Yukiko Sugawara; Akiomi Yoshihisa; Shinji Ishibashi; Mitsuko Matsuda; Yukio Yamadera; Himika Ohara; Yasuhiro Ichijo; Koichiro Watanabe; Yu Hotsuki; Fumiya Anzai; Yu Sato; Yusuke Kimishima; Tetsuro Yokokawa; Tomofumi Misaka; Shinya Yamada; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Yasuchika Takeishi
Journal:  CJC Open       Date:  2021-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.